Strategic partners
The International MPS Network (IMPSN) thrives on the collective strength of its Strategic Partners—a diverse and dedicated group consisting of individuals and organizations united in the mission to improve the lives of those affected by MPS and related disorders.
Meet Our Partners
We welcome partnerships with:
Organizations
- Pharmaceutical and Biotech Companies
- Advocacy Organizations and Alliances
- Healthcare and Research Institutions
- Newborn Screening and Diagnostics Groups
- Corporate Partners (CSR and Philanthropy)
- Education and Training Institutions
- Nonprofit and Community Foundations
- Technology and AI Companies Focused on Healthcare
- Regional and Local Patient Advocacy Groups
- Global Health Organizations
- Professional Societies and Conferences
- Contract Research Organizations (CROs)
Individuals
- Patients, caregivers, and family members seeking to collaborate and share insights.
- Physicians and healthcare providers specializing in MPS and related LSDs.
- Researchers advancing science and innovation in lysosomal storage diseases.
- Students exploring careers in rare disease advocacy, care, or research.
- Academics contributing to education or policy in rare diseases.
How to Become a Strategic Partner
Becoming a Strategic Partner with the IMPSN is an opportunity to join a global alliance dedicated to meaningful change. Partners can engage in several ways, such as contributing expertise, funding initiatives, participating in collaborative research, hosting events, or offering in-kind resources and services.
